Lir Life Sciences Corp. (CVE:SKNY) | Finanzwire

Basculer en Français

10591	Companies
224574	Keywords
153308	Articles
118793	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

BRIEF

published on 06/18/2026 at 00:05, 2 hours 14 minutes ago

LIR Life Sciences Unveils Successful Study on Protamine-Enhanced Permeation

Study Results Needle-free Therapies Protamine-enhanced Delivery GLP/GIP-based Therapies Semaglutide And Tirzepatide
PRESS RELEASE

published on 06/18/2026 at 00:00, 2 hours 19 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
LIR Life Sciences Corp. announces successful completion of comparative mouse study evaluating skin-permeation delivery of GLP/GIP-based therapies. Results presented at ENDO 2026

Lir Life Sciences Corp. GLP/GIP-based Therapies Comparative Mouse Study Skin-permeation Delivery ENDO 2026
BRIEF

published on 05/23/2026 at 01:05, 26 days 1 hour ago

LIR Life Sciences Initiates Phase 1 Transdermal Delivery Development

Transdermal Delivery LIR Life Sciences Neuland Laboratories Phase 1 Development Macromolecule Synthesis
PRESS RELEASE

published on 05/23/2026 at 01:00, 26 days 1 hour ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Neuland Laboratories Limited orders raw materials for Phase 1 of macromolecule-enabled transdermal delivery development with LIR Life Sciences Corp. to advance needle-free, skin-applied peptide therapies

Phase 1 Lir Life Sciences Corp. Neuland Laboratories Limited Macromolecule-enabled Transdermal Delivery Needle-free Peptide Therapies
BRIEF

published on 04/29/2026 at 00:05, 1 month 19 days ago

LIR Life Sciences Initiates Ex Vivo Study on Protamine's Efficacy in Transdermal Delivery

Ex Vivo Study Needle-free Delivery Protamine Enhancement Transdermal Transport Therapeutic Molecules
PRESS RELEASE

published on 04/29/2026 at 00:00, 1 month 19 days ago

LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
LIR Life Sciences Corp. announces the launch of a controlled ex vivo porcine skin study to evaluate protamine's impact on transdermal movement of macromolecular therapeutics. The study aims to advance needle-free delivery options for larger molecules

Transdermal Delivery Lir Life Sciences Corp. Needle-free Delivery Protamine Macromolecular Therapeutics
BRIEF

published on 04/21/2026 at 00:05, 1 month 27 days ago

LIR Life Sciences Corp. Partners with Resilience BioSciences Inc.

Drug Development Preclinical Research Technology Collaboration Novel Therapies Academic Environment
PRESS RELEASE

published on 04/21/2026 at 00:00, 1 month 27 days ago

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
LIR Life Sciences Corp. announces a Technology Development Collaboration Agreement with Resilience BioSciences Inc. to enhance preclinical research activities in drug discovery and development

Drug Discovery Life Sciences Collaboration Agreement Preclinical Research Resilience BioSciences
BRIEF

published on 02/06/2026 at 00:05, 4 months 12 days ago

LIR Life Sciences Initiates Phase 2 Peptide Design with Neuland Laboratories

Transdermal Delivery LIR Life Sciences Neuland Laboratories Peptide Design Structure-Activity Relationships
PRESS RELEASE

published on 02/06/2026 at 00:00, 4 months 12 days ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
LIR Life Sciences Corp. announces commencement of Project Phase 2 peptide design activities with Neuland Laboratories Limited, focusing on next-generation cell-penetrating peptides for transdermal delivery platform optimization

Transdermal Delivery Lir Life Sciences Corp. Peptide Design Project Phase 2 Neuland Laboratories Limited

Accesswire

Published on 06/18/2026 at 00:00, 2 hours 19 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 2 hours 49 minutes ago

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 3 hours 29 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 3 hours 49 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 9 hours 24 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE

EQS Group

Published on 06/17/2026 at 21:40, 4 hours 39 minutes ago

Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 7 hours 9 minutes ago

Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 7 hours 39 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 7 hours 43 minutes ago

BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 7 hours 56 minutes ago

EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG

Les Echos

Published on 06/17/2026 at 17:40, 8 hours 39 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 17 hours 34 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 14 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 3 hours ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 7 hours ago

Reporting on share buyback transactions carried out between June 8 and June 11, 2026

View all LES ECHOS COMFI WIRE